These educational programs address health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with breast cancer. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most current treatment recommendations for breast cancer.

Intended Audience
These activities are designed to meet the educational needs of medical oncologists, radiation oncologists, surgical oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with breast cancer.

Accreditation
These activities are approved for AMA PRA Category 1 Credit(s)™. Nursing and pharmacy (ACPE) credits are provided for all activities as well. Complete accreditation information is provided before each activity.

Fee Information
There is no fee for these educational activities.

Supporters
Supported by educational grants from AstraZeneca LP; Eisai Inc.; Genentech, USA; Genomic Health, Inc.; and Novartis Pharmaceuticals Corporation

Click the title of an activity below to proceed.